Literature DB >> 10647517

Anatomic considerations of a modified anterior approach to the cervicothoracic junction.

R Xu1, R Grabow, N A Ebraheim, S J Durham, R A Yeasting.   

Abstract

The results of a study on 30 adult human cadavers showed that the anterior aspect of T-3 can be easily exposed through a modified anterior approach to the cervicothoracic spinal junction. Anterior exposure of T-4 caused significant tension on the brachiocephalic vein in 57%; in 7% the vein actually tore. The location of the vital structures is as follows: the left brachiocephalic vein is at T-1 and T-2 in 80%; the aortic arch is at T-2 and T-3 in 90%; the right recurrent laryngeal nerve reaches the tracheoesophageal groove at the level of C-6 in 50%; the thoracic duct empties into the systemic venous system from C-7 to T-2. Adequate exposure of the low cervical to the upper thoracic spine can be obtained with this approach. Preoperative computed tomographic evaluation of the location of the left brachiocephalic vein with respect to the vertebral levels is recommended.

Entities:  

Mesh:

Year:  2000        PMID: 10647517

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  3 in total

1.  Anterior approaches to the cervicothoracic junction: a study on the surgical accessibility of three different corridors based on the CT images.

Authors:  Yi-Xing Huang; Wen-Fei Ni; Sheng Wang; Hui Xu; Xiang-Yang Wang; Hua-Zi Xu; Yong-Long Chi; Jia-Wei He
Journal:  Eur Spine J       Date:  2010-06-13       Impact factor: 3.134

2.  Anterior decompression for cervicothoracic pathology: A study of 14 patients.

Authors:  M M Prabhakar; Tejas Thakker
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

3.  Mini Transsternal Approach to the Anterior High Thoracic Spine (T1-T4 Vertebrae).

Authors:  Christian Brogna; Bhaskar Thakur; Leslie Fiengo; Sandra Maria Tsoti; Alessandro Landi; Giulio Anichini; Francesco Vergani; Irfan Malik
Journal:  Biomed Res Int       Date:  2016-04-27       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.